BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
EGFR
,
Angiogenesis
,
HIV infection
,
Adipose tissue
,
Neocentromeres
,
Prozac
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ofatumumab
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS …
Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis …
A meaningful exploration of ofatumumab in refractory NMOSD: a case report.
Evaluating the impact of early vs delayed ofatumumab initiation and estimating the long-term outcome…
To wait, or too late? Modeling the effects of delayed ofatumumab treatment in relapsing-remitting mu…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment
Characterizing the Use of Ofatumumab in a Real World Setting
Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study
Time and Motion Study for Ocrelizumab and Ofatumumab Administration in Relapsing Multiple Sclerosis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ